Peter Bernhardt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Peter Bernhardt

Showing results (211-220 of 224) with videos related to

Pageof 23

Sort By:

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025

Preclinical Validation of [177Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human TrialsAnja C L Mortensen, Tabassom Mohajershojai, Amanda Gustafsson, et al.

European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2024

First-in-human administration of [161Tb]Tb-SibuDAB and comparative dosimetry with standard [177Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia studyAlin Chirindel, Guillaume P Nicolas, Frida Westerbergh, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021

First-in-Humans Application of 161Tb: A Feasibility Study Using 161Tb-DOTATOCRichard P Baum, Aviral Singh, Harshad R Kulkarni, et al.

Clinical Transplantation|July 3, 2021

Everolimus-facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2-year results from the subgroup analysis of the TRANSFORM studyYoshihiko Watarai, Romina Danguilan, Concesa Casasola, et al.

Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 2, 2020

Sealing of Coronary Perforations With a Second-Generation Covered Stent Graft - Results From the PAST-PERF RegistryRalf Birkemeyer, Göran K Olivecrona, Farrel Hellig, et al.

Journal of the American Society of Nephrology : JASN|May 13, 2018

Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2004

Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studiesStefan Vitko, Helio Tedesco, Josette Eris, et al.

Biochemistry|August 19, 2022

Structural Basis of Stereospecific Vanadium-Dependent Haloperoxidase Family Enzymes in Napyradiomycin BiosynthesisPercival Yang-Ting Chen, Sanjoy Adak, Jonathan R Chekan, et al.

European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2023

Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetryPablo Mínguez Gabiña, Katarina Sjögreen Gleisner, Marta Cremonesi, et al.

JACC. Cardiovascular Imaging|September 13, 2014

Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patientsMatthijs van Kranenburg, Michael Magro, Holger Thiele, et al.

Pageof 23

Search research articles

Showing results (211-220 of 224) with videos related to

Sort By:

Pageof 23

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025

Preclinical Validation of [177Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human TrialsAnja C L Mortensen, Tabassom Mohajershojai, Amanda Gustafsson, et al.

European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2024

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021

First-in-Humans Application of 161Tb: A Feasibility Study Using 161Tb-DOTATOCRichard P Baum, Aviral Singh, Harshad R Kulkarni, et al.

Clinical Transplantation|July 3, 2021

Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 2, 2020

Sealing of Coronary Perforations With a Second-Generation Covered Stent Graft - Results From the PAST-PERF RegistryRalf Birkemeyer, Göran K Olivecrona, Farrel Hellig, et al.

Journal of the American Society of Nephrology : JASN|May 13, 2018

Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2004

Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studiesStefan Vitko, Helio Tedesco, Josette Eris, et al.

Biochemistry|August 19, 2022

Structural Basis of Stereospecific Vanadium-Dependent Haloperoxidase Family Enzymes in Napyradiomycin BiosynthesisPercival Yang-Ting Chen, Sanjoy Adak, Jonathan R Chekan, et al.

European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2023

Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetryPablo Mínguez Gabiña, Katarina Sjögreen Gleisner, Marta Cremonesi, et al.

JACC. Cardiovascular Imaging|September 13, 2014

Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patientsMatthijs van Kranenburg, Michael Magro, Holger Thiele, et al.

Pageof 23